Novel tripeptidyl C-terminal Michael acceptors with an ester replacement of
the P-2-P-3 amide bond were investigated as irreversible inhibitors of the
human rhinovirus (HRV) 3C protease (3CP). When screened against HRV seroty
pe-14 the best compound was shown to have very good 3CP inhibition (k(obs)/
[I]=270,000 M(-1)s(-1)) and potent in vitro antiviral activity (EC50 = 7.0
nM). (C) 2001 Elsevier Science Ltd. All rights reserved.